InvestorsHub Logo
Followers 69
Posts 7941
Boards Moderated 0
Alias Born 01/29/2015

Re: None

Thursday, 07/14/2022 1:09:04 AM

Thursday, July 14, 2022 1:09:04 AM

Post# of 16707
Hey Kool-Aid! Oh, Yeah!

That about sums up any hype about receiving Topline data results for a study that was due at minimum a year ago. What we do know is whatever the data suggests it won't be enough to move to Phase 3. The question is whether or not the data is even relevant enough to warrant running another Phase 2 study much less ever getting to a Phase 3 study? What we also know is there is currently zero funds to run a true Phase 2 study powered for stat sig. We also know if such a study were to occur in your lifetime they are planning to go back to Australia where there's a snails pace enrollment rate and a country willing to shut down 100% during pandemics. The covid variants are still out there.

Meanwhile, Christopher Joseph Moreau has the luck of a Death Row inmate. I wouldn't put it past lightning striking twice in Australia for another study stretching out 2 or 3 or more years in the Land Down Under with a lived experience by shareholders the likes of Dante's Inferno. Your leaders have their heads in the sand like Ostriches. They will slow roll giving Bellus Health a billion dollar market cap run for the money to instead pursue massive dilution Phase 1 studies. Anyone thinks Wall Street is interested in that scenario? Where Algernon finds the 8MUSD for everything but a Randomized Double-blind Placebo Controlled Chronic Cough study conducted in North America remains a mystery meat pie in the sky from what I can tell.

Algernon's mystery meat pie pairs well with Kool-Aid.

Bon Appetit

M$